Analysts expect Oklo Inc. to report a Q2 2026 loss of $0.17 per share on nominal revenue of $0.08 million, with the stock currently trading at $43.36 against a consensus price target of $88.00.
The key story for investors is the updated commercialization timeline for the Aurora powerhouse and progress regarding its Nuclear Regulatory Commission (NRC) licensing. Market sentiment has been buoyed by recent technical milestones, such as the U.S. Department of Energy’s startup authorization for a Texas isotope reactor and a strategic partnership with Meta Platforms.
Management’s guidance on capital allocation for its $2.5 billion cash balance and the conversion of its massive project pipeline into firm agreements remains the primary focus.